TMAM
EPZM

Tokio Marine Asset Management’s Epizyme, Inc EPZM Stock Holding History

Tokio Marine Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,183
Closed -$164K – 301
2020
Q2 		$164K Buy
+10,183
New +$178K 0.02% 252

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Tokio Marine Asset Management's EPZM Position: Q3 2020 in Review

Tokio Marine Asset Management sold out of Epizyme, Inc (EPZM) in Q3 2020, closing a stake of 10,183 shares — an estimated $164K sold.

Tokio Marine Asset Management first reported a position in EPZM in Q2 2020 and held it in 1 quarter. The position peaked at $164K in Q2 2020. 151 funds tracked by Wall St. Rank hold EPZM as of Q3 2020.

  • Tokio Marine Asset Management reported no remaining Epizyme, Inc position as of Q3 2020 after selling out during the quarter.
  • Tokio Marine Asset Management sold 10,183 Epizyme, Inc shares in Q3 2020, an estimated $164K.
  • Tokio Marine Asset Management first reported a position in Epizyme, Inc in Q2 2020 and held it in 1 quarter.
  • Tokio Marine Asset Management's Epizyme, Inc position peaked at $164K in Q2 2020.
  • 151 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2020.

Based on Tokio Marine Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.